Principal Financial Group Inc Seres Therapeutics, Inc. Transaction History
Principal Financial Group Inc
- $162 Billion
- Q1 2024
A detailed history of Principal Financial Group Inc transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Principal Financial Group Inc holds 27,088 shares of MCRB stock, worth $19,503. This represents 0.0% of its overall portfolio holdings.
Number of Shares
27,088
Previous 61,664
56.07%
Holding current value
$19,503
Previous $86,000
76.74%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding MCRB
# of Institutions
100Shares Held
62.7MCall Options Held
36.9KPut Options Held
476K-
Flagship Pioneering Inc. Cambridge, MA23.1MShares$16.6 Million1.17% of portfolio
-
Black Rock Inc. New York, NY6.83MShares$4.91 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.73MShares$4.85 Million0.0% of portfolio
-
Hudson Bay Capital Management LP Greenwich, CT5.43MShares$3.91 Million0.03% of portfolio
-
Geode Capital Management, LLC Boston, MA2.13MShares$1.54 Million0.0% of portfolio
About Seres Therapeutics, Inc.
- Ticker MCRB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 124,072,000
- Market Cap $89.3M
- Description
- Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...